Prenatal diagnosis of bone dysplasias

Gen Nishimura1, Atsuhiko Handa2, Osamu Miyazaki1,3

  • 1Japan Forum of Fetal Skeletal Dysplasia, Tokyo, Japan.

Insights

Prenatal diagnosis of bone dysplasias relies on imaging, even with genetic testing. Ultrasound, MRI, and CT are crucial for identifying skeletal disorders and guiding decisions when genetic tests are inconclusive.

Area of Science:

  • Medical Imaging
  • Prenatal Diagnosis
  • Skeletal Dysplasias

Background:

  • Bone dysplasias are a diverse group of genetic skeletal disorders, with over 400 identified.
  • While individually rare, they are collectively common, posing diagnostic challenges in obstetrics.
  • Commonly encountered types include FGFR3-related dysplasias, osteogenesis imperfecta, and type II collagenopathies.

Purpose of the Study:

  • To emphasize the critical role of imaging in diagnosing bone dysplasias prenatally.
  • To highlight key imaging findings for common bone dysplasias.
  • To guide rational decision-making in prenatal diagnosis, complementing genetic testing.

Main Methods:

  • Review of imaging modalities used for prenatal diagnosis of bone dysplasias.
  • Focus on ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT).
  • Correlation of imaging findings with clinical presentation and genetic information.

Main Results:

  • Limb shortening on screening ultrasound is a primary indicator for suspecting bone dysplasias.
  • Detailed ultrasound, MRI, and CT provide essential information for diagnosis.
  • Imaging is vital for assessing pathogenicity, as genetic variants alone may be insignificant.

Conclusions:

  • Imaging remains indispensable for the definitive diagnosis of bone dysplasias, despite advances in genetic testing.
  • A combination of imaging techniques allows for accurate assessment and management planning.
  • Rational decision-making is achievable through comprehensive imaging analysis in prenatal settings.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
6.4K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
4.8K
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Karyotyping01:17

Karyotyping

Overview
61.9K